Thermopylae Holdings Ltd., 10% Owner at AbCellera Biologics Inc. (ABCL), bought 177,457 shares at $3.27 ($580K) on 2026-02-26, disclosed to the SEC on 2026-02-27.
Open-market purchase of $580k ABCL by 10% Owner. Below the thresholds we flag for high-conviction alerts (no C-suite role, rare reversal, cluster, or A-grade history). Context: insider career grade B.
Negative factors outweigh the positive ones.
| Filing → |
| ABCL | BUY | 2024-08-29 | $1.5M | — | Filing → |
| ABCL | BUY | 2023-05-26 | $2.0M | — | Filing → |
| ABCL | BUY | 2022-12-20 | $1.7M | — | Filing → |